Home / Inspections / 796372

FDA Inspection 796372 — Medefil Incorporated

Medefil Incorporated — FEI 3001677091

The FDA completed an inspection of Medefil Incorporated on August 22, 2012 in Glendale Heights, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 22, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Glendale Heights, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1251304 (VAI Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1046065 (VAI Thu Mar 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 976257 (VAI Fri Jun 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 894968 (VAI Mon Sep 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 808935 (VAI Thu Dec 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources